AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance ...
The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback